-
Pharmacy benefit managers attempt to negotiate cost savings for insurers. California is considering new rules that would require them to pass their discounts on to consumers.
-
As Oregon moves closer to limiting prescription drug prices, the pharmaceutical industry has stepped up its efforts targeting the state board that could set those limits.
-
Oregon House Bill 4149 will regulate these middlemen in the drug market
-
Secretary of State auditors recommend changes to provide equal prescription access to all Oregon Health Plan members.
-
To fight the skyrocketing cost of insulin, California is using multiple tactics, including making its own generic versions.
-
Under the $50 million deal, the state is partnering with drugmaker Civica to start making the new generic insulin later this year, Gov. Gavin Newsom said.
-
Centene Corp. has agreed to pay more than $215 million to California over allegations it overcharged the state for pharmacy services — the biggest payout to date by the nation’s largest Medicaid insurer over its drug pricing practices.
-
California plans to roll out an ambitious plan to manufacture its own insulin, but in the meantime, legislators are proposing to cap what diabetics pay.
-
The legislation has been a year in the making, with tense negotiations leading to a narrower spending package that focuses on climate investments and health care costs.
-
Gov. Gavin Newsom’s administration is pushing a first-in-the-nation plan for California to partner with a drugmaker to produce cheaper insulin. It’s one of many proposed state and federal remedies to soaring insulin costs.
-
It won’t surprise you to hear that getting a prescription filled in Oregon is getting more expensive each year. But according to a soon-to-be-released state report, drug price increases overall are getting fewer, and smaller.
-
The price of many prescription drugs has been rising dramatically in recent years. This week, Oregonians will have a chance to give testimony about how those prices are affecting their ability to afford their medication.
-
Democrats agreed to a significant — but slimmed down — proposal to help lower prescription drug prices, bringing aboard notable holdouts on the measure, including Arizona Sen. Kyrsten Sinema.
-
Price spikes of prescription drugs are the focus of a new report from the Oregon Prescription Drug Price Transparency Program. Included in its findings…